Dr. Pulsipher is currently the Division Chief of the Pediatric Hematology at Intermountain Primary Children's Hospital and Oncology, Director of the Children's and Adolescent Cancer Initiative at Huntsman Cancer Institute and a Presidential Chair in Pediatric Oncology and Hematology at the University of Utah. �Dr. Pulsipher is an internationally recognized expert in Bone Marrow Transplantation and Cellular Therapy, having directed the world's largest pediatric transplant research group for more than a decade (Pediatric Transplantation and Cellular Therapy Consortium). �He has run more than 20 multicenter trials in the field and is considered and expert in broad areas of transplantation and cellular therapy. �Areas of focus have included development of reduced toxicity approaches to transplantation of both malignant and non-malignant disorders with a focus on minimizing short and long-term effects of transplant. �For non-malignant disorders he has run national protocols that have improved safety for patients with immunodeficiencies, HLH, and bone marrow failure. For cancer, he has developed techniques allowing identification of patients who can avoid radiation-based treatments for leukemia. �This has included a novel approach to safer transplantation of patients using half-matched family donors (haploidentical donors) using a novel form of bone marrow graft engineering called alpha-beta T-cell depletion. �His desire to develop safer approaches has become a major focus as he has led major studies in the field of chimeric antigen receptor T-cells (CAR T-cells), a safer approach to cancer cure. �Dr. Pulsipher's work in cell therapy helped lead to the FDA approval of the first CART cell treatment, tisagenlecleucel, and he continues to run trials in CAR T, NK, and Viral Specific T-cell therapies. He has open protocols aimed at improving outcomes and his lab efforts are focused on making CAR T-cells that last longer and avoid overcome resistance by cancer cells. Dr. Pulsipher's interests have included ensuring that the families of those undergoing transplantation and cell therapy are psychologically well throughout the process. �To help with this, he has run several large trials assessing the safety and Quality of Life of pediatric bone marrow donors and is he currently running a large national trial looking at the psychological well-being of donor and recipient families as they go through the transplant process.For questions regarding Dr. Pulsipher's adult practice at the Huntsman Cancer Institute, or for questions about any of our clinical programs and for assistance identifying the right Hematology specialist for you or your family member, please contact our Clinical Care Specialist/New Patient Coordinator at (801) 587-4652. For questions regarding Dr. Pulsipher's pediatric practice and the Blood and Marrow Transplant Program at Primary Children's Medical Center, please call (801) 662-4830. Dr. Pulsipher is rated as an Experienced provider by MediFind in the treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH). His top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Graft Versus Host Disease (GvHD), Leukemia, Severe Combined Immunodeficiency (SCID), and Bone Marrow Transplant.

Charles Parker is a Hematologist and a Hematologist Oncology provider in Salt Lake City, Utah. Dr. Parker is rated as an Advanced provider by MediFind in the treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH). His top areas of expertise are Hemochromatosis, Pure Red Cell Aplasia, Fanconi Anemia, Acute Hepatic Porphyria (AHP), and Bone Marrow Aspiration. Dr. Parker is currently accepting new patients.

Finn Petersen is a Hematologist Oncology specialist and a Hematologist in Salt Lake City, Utah. Dr. Petersen is rated as an Experienced provider by MediFind in the treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH). His top areas of expertise are Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Acute Myeloblastic Leukemia with Maturation, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Petersen is currently accepting new patients.

Srinivas Tantravahi is a Hematologist in Salt Lake City, Utah. Dr. Tantravahi is rated as an Experienced provider by MediFind in the treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH). His top areas of expertise are Chronic Myelogenous Leukemia (CML), Chronic Myelomonocytic Leukemia (CMML), Myelofibrosis, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Tantravahi is currently accepting new patients.

Ming Lim is a Hematologist Oncology specialist and a Hematologist in Salt Lake City, Utah. Dr. Lim is rated as an Experienced provider by MediFind in the treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH). Her top areas of expertise are Blood Clots, Hemophilia A, Thrombocytopenia, Von Willebrand Disease (VWD), and Bone Marrow Aspiration. Dr. Lim is currently accepting new patients.

Nitin Chandramouli is a Hematologist in Salt Lake City, Utah. Dr. Chandramouli is rated as an Experienced provider by MediFind in the treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH). His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Laryngeal Cancer, and Hartsfield Syndrome.

Xylina Gregg is an Oncologist and a Hematologist in Salt Lake City, Utah. Dr. Gregg is rated as an Experienced provider by MediFind in the treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH). Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Vulvar Cancer, and Familial Colorectal Cancer. Dr. Gregg is currently accepting new patients.

Stephan Kendall is an Oncologist and a Hematologist in Salt Lake City, Utah. Dr. Kendall is rated as an Experienced provider by MediFind in the treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH). His top areas of expertise are Thrombocytopenia, Drug-Induced Thrombocytopenia, Agranulocytosis, Chronic Familial Neutropenia, and Bone Marrow Aspiration.

Lindsay Hunter is a Hematologist Oncology provider in Murray, Utah. Dr. Hunter has been practicing medicine for over 10 years and is rated as an Experienced provider by MediFind in the treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH). Her top areas of expertise are HER-2 Positive Breast Cancer, Dehydration, Breast Cancer, and Paget Disease of the Breast. Dr. Hunter is currently accepting new patients.

Jonathan Whisenant is an Oncologist in Murray, Utah. Dr. Whisenant has been practicing medicine for over 28 years and is rated as an Experienced provider by MediFind in the treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH). His top areas of expertise are Cholangiocarcinoma (Bile Duct Cancer), Gastrointestinal Stromal Tumor, Colorectal Cancer, and Familial Colorectal Cancer. Dr. Whisenant is currently accepting new patients.